The FDA has approved the expanded use of Regeneron's drug Evkeeza in children to treat a rare disease that causes high cholesterol. 

The FDA has approved the expanded use of Regeneron's drug Evkeeza in children to treat a rare disease that causes high cholesterol.&nbsp;

Need2Know Headlines

FDA Expands Use Of Regeneron's Children Cholesterol Drug Evkeeza

The FDA has approved the expanded use of Regeneron's drug in Children aged 5 to 11 years old to treat a rare disease that causes high cholesterol. The condition is called home Homozygous familial hypercholesterolemia. About 200 pediatric patients suffer from this. According to the drugmaker, the expanded approval makes Regeneron's drug called Evkeeza the first drug to treat kids under the age of 10. With this disorder.